Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Multiple Sclerosis

Free Subscription Articles published in Neurology Retrieve available abstracts of 221 articles: HTML format Text format

Single Articles

March 2010
1. SARGSYAN SA , Shearer AJ, Ritchie AM, Burgoon MP, et al
   Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
   Neurology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. RIVERA VM
   The challenge of follow-on biologics for treatment of multiple sclerosis.
   Neurology. 2010;74:864.
   PubMed     Text format     Related articles   
   
   
   
3. DAVIS M , Auh S, Riva M, Richert ND, et al
   Ring and nodular multiple sclerosis lesions: A retrospective natural history study.
   Neurology. 2010;74:851-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. FOX RJ
   Primary neuroprotection. The Holy Grail of multiple sclerosis therapy.
   Neurology. 2010.
   PubMed     Text format     Related articles   
   
   
   
5. BARKHOF F , Hulst HE, Drulovic J, Uitdehaag BM, et al
   Ibudilast in relapsing-remitting multiple sclerosis. A neuroprotectant?
   Neurology. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. ZELLER D , Aufm Kampe K, Biller A, Stefan K, et al
   Rapid-onset central motor plasticity in multiple sclerosis.
   Neurology. 2010;74:728-35.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
7. HOFER S , Linnebank M, Weller M, Bahmanyar S, et al
   Cancer risk among patients with multiple sclerosis and their parents.
   Neurology. 2010;74:614-5.
   PubMed     Text format     Related articles   
   
   
   
8. PENNY S , Khaleeli Z, Cipolotti L, Thompson A, et al
   Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis.
   Neurology. 2010;74:545-52.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. BENARROCH EE
   Adenosine triphosphate: a multifaceted chemical signal in the nervous system.
   Neurology. 2010;74:601-7.
   PubMed     Text format     Related articles   
   
   
   
10. GUTWINSKI S , Erbe S, Munch C, Janke O, et al
    Severe cutaneous Candida infection during natalizumab therapy in multiple sclerosis.
    Neurology. 2010;74:521-3.
    PubMed     Text format     Related articles   
    
    
    
11. CHABAS D , Ness J, Belman A, Yeh EA, et al
    Younger children with MS have a distinct CSF inflammatory profile at disease onset.
    Neurology. 2010;74:399-405.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
12. CALABRESE M , Rinaldi F, Mattisi I, Grossi P, et al
    Widespread cortical thinning characterizes patients with MS with mild cognitive impairment.
    Neurology. 2010;74:321-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. WEINSTOCK-GUTTMAN B , Ramanathan M, Hashmi K, Abdelrahman N, et al
    Increased tissue damage and lesion volumes in African Americans with multiple sclerosis.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. CREE B , Waubant E
    Does race matter for multiple sclerosis?
    Neurology. 2010.
    PubMed     Text format     Related articles   
    
    
    
15. MARRIE RA , Yu N, Blanchard J, Leung S, et al
    The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. ROCCA MA , Ceccarelli A, Rodegher M, Misci P, et al
    Preserved brain adaptive properties in patients with benign multiple sclerosis.
    Neurology. 2010;74:142-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. OKADA K , Matsushita T, Kira J, Tsuji S, et al
    B-cell activating factor of the TNF family is upregulated in neuromyelitis optica.
    Neurology. 2010;74:177-8.
    PubMed     Text format     Related articles   
    
    
    
18. MONTALBAN X , Tintore M, Swanton J, Barkhof F, et al
    MRI criteria for MS in patients with clinically isolated syndromes.
    Neurology. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. PAPPAS DJ , Oksenberg JR
    Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy.
    Neurology. 2010;74 Suppl 1:S62-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. LEIST TP , Marks S
    Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics.
    Neurology. 2010;74 Suppl 1:S54-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. RAMMOHAN KW , Shoemaker J
    Emerging multiple sclerosis oral therapies.
    Neurology. 2010;74 Suppl 1:S47-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. RACKE MK , Lovett-Racke AE, Karandikar NJ
    The mechanism of action of glatiramer acetate treatment in multiple sclerosis.
    Neurology. 2010;74 Suppl 1:S25-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. KASPER LH , Shoemaker J
    Multiple sclerosis immunology: The healthy immune system vs the MS immune system.
    Neurology. 2010;74 Suppl 1:S2-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. DHIB-JALBUT S , Marks S
    Interferon-beta mechanisms of action in multiple sclerosis.
    Neurology. 2010;74 Suppl 1:S17-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. LISAK RP , Korngold S
    Insights for practice: where mechanism of action meets patient management.
    Neurology. 2010;74 Suppl 1:S70-3.
    PubMed     Text format     Related articles   
    
    
    
26. VOLLMER T , Stewart T, Baxter N
    Mitoxantrone and cytotoxic drugs' mechanisms of action.
    Neurology. 2010;74 Suppl 1:S41-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. BIELEKOVA B , Becker BL
    Monoclonal antibodies in MS: mechanisms of action.
    Neurology. 2010;74 Suppl 1:S31-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
28. RAMAGOPALAN SV , Link J, Byrnes JK, Dyment DA, et al
    HLA-DRB1 and month of birth in multiple sclerosis.
    Neurology. 2009;73:2107-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. KOCH M , Kingwell E, Rieckmann P, Tremlett H, et al
    The natural history of primary progressive multiple sclerosis.
    Neurology. 2009;73:1996-2002.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. SELLEBJERG F , Bornsen L, Khademi M, Krakauer M, et al
    Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
    Neurology. 2009;73:2003-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. TENSER RB , Ebers GC, Daumer M
    MRI asanoutcomein multiple sclerosis clinical trials.
    Neurology. 2009;73:1933-4.
    PubMed     Text format     Related articles   
    
    
    
32. SORMANI MP , Filippi M, De Stefano N, Ebers G, et al
    MRI ASANOUTCOMEIN MULTIPLE SCLEROSIS CLINICAL TRIALS.
    Neurology. 2009;73:1932-1933.
    PubMed     Text format     Related articles   
    
    
    
33. THURTELL MJ , Bala E, Yaniglos SS, Rucker JC, et al
    Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials.
    Neurology. 2009;73:1849-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. TEUNISSEN CE , Petzold A, Bennett JL, Berven FS, et al
    A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
    Neurology. 2009;73:1914-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. MARTINELLI V , Rocca MA, Annovazzi P, Pulizzi A, et al
    A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
    Neurology. 2009;73:1842-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. JAFARI N , Kreft KL, Flach HZ, Janssens AC, et al
    Callosal lesion predicts future attacks after clinically isolated syndrome.
    Neurology. 2009;73:1837-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
37. DAROFF RB , Dell'osso LF, Frohman Faan EM, Beeravolu LR, et al
    "NOT MULTIPLE SCLEROSIS" AND THE CHANGING FACE OF HTLV-1: A CASE REPORT OF DOWNBEAT NYSTAGMUS.
    Neurology. 2009;73:1812-1813.
    PubMed     Text format     Related articles   
    
    
    
38. KELLY VM , Nelson LM, Chakravarty EF
    Obstetric outcomes in women with multiple sclerosis and epilepsy.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. FRANKLIN GM , Tremlett H
    Multiple sclerosis and pregnancy. What should we be telling our patients?
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
40. MOORE F , Okuda DT
    Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
    Neurology. 2009;73:1714.
    PubMed     Text format     Related articles   
    
    
    
41. BELLMANN-STROBL J , Wuerfel J, Aktas O, Dorr J, et al
    Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Neurology. 2009;73:1624-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. MARRIE RA , Cutter G
    Relapses in multiple sclerosis. Important or not?
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
43. TREMLETT H , Yousefi M, Devonshire V, Rieckmann P, et al
    Impact of multiple sclerosis relapses on progression diminishes with time.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. DALGAS U , Stenager E, Jakobsen J, Petersen T, et al
    Resistance training improves muscle strength and functional capacity in multiple sclerosis.
    Neurology. 2009;73:1478-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. PACHNER AR , Warth JD, Pace A, Goelz S, et al
    Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study.
    Neurology. 2009;73:1493-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. PACHNER AR , Cadavid D, Wolansky L, Skurnick J, et al
    Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study.
    Neurology. 2009;73:1485-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
47. MARRIE RA , Cutter G, Tyry T, Vollmer T, et al
    A cross-sectional study of bone health in multiple sclerosis.
    Neurology. 2009;73:1394-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. ZORRO O , Lobato-Polo J, Kano H, Flickinger JC, et al
    Gamma knife radiosurgery for multiple sclerosis-related trigeminal neuralgia.
    Neurology. 2009;73:1149-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
49. SALVATORE E , Morra VB, Orefice G
    Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Neurology. 2009;73:1078.
    PubMed     Text format     Related articles   
    
    
    
50. ENGEL WK
    Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Neurology. 2009;73:1077.
    PubMed     Text format     Related articles   
    
    
    
51. VAN DER WALT A , Stankovich J, Bahlo M, Taylor BV, et al
    Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
    Neurology. 2009;73:1018-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. DORR J , Bitsch A, Schmailzl KJ, Chan A, et al
    Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
    Neurology. 2009;73:991-3.
    PubMed     Text format     Related articles   
    
    
    
53. KLAWITER EC , Cross AH, Naismith RT
    The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%?
    Neurology. 2009;73:984-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. LLUFRIU S , Castillo J, Blanco Y, Ramio-Torrenta L, et al
    Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
    Neurology. 2009;73:949-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. MENGE T , Schloot NC, Schott M, Hemmer B, et al
    Interferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosis.
    Neurology. 2009;73:900-2.
    PubMed     Text format     Related articles   
    
    
    
56. MATTA M , Leigh RJ, Pugliatti M, Aiello I, et al
    Using fast eye movements to study fatigue in multiple sclerosis.
    Neurology. 2009;73:798-804.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. HEDSTROM AK , Baarnhielm M, Olsson T, Alfredsson L, et al
    Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
    Neurology. 2009;73:696-701.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
58. PIRKO I , Zivadinov R
    Transcranial sonography of deep gray nuclei. A new outcome measure in multiple sclerosis?
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
59. CHARD DT , Miller DH
    What you see depends on how you look. Gray matter lesions in multiple sclerosis.
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
60. REINGOLD SC , Steiner JP, Polman CH, Cohen JA, et al
    The challenge of follow-on biologics for treatment of multiple sclerosis.
    Neurology. 2009;73:552-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. ZIVADINOV R , Weinstock-Guttman B, Hashmi K, Abdelrahman N, et al
    Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis.
    Neurology. 2009;73:504-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. BENEDICT RH , Fazekas F
    Benign or not benign MS: a role for routine neuropsychological assessment?
    Neurology. 2009;73:494-5.
    PubMed     Text format     Related articles   
    
    
    
63. WALTER U , Wagner S, Horowski S, Benecke R, et al
    Transcranial brain sonography findings predict disease progression in multiple sclerosis.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. HESSE D , Sellebjerg F, Sorensen PS
    Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity.
    Neurology. 2009;73:372-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
65. PORTACCIO E , Stromillo ML, Goretti B, Zipoli V, et al
    Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. ROSE JW
    Multiple sclerosis. Evidence of maternal effects and an increasing incidence in women.
    Neurology. 2009.
    PubMed     Text format     Related articles   
    
    
    
67. MAINERO C , Benner T, Radding A, van der Kouwe A, et al
    In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. RATCHFORD JN , Quigg ME, Conger A, Frohman T, et al
    Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies.
    Neurology. 2009;73:302-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. LUNEMANN JD , Ascherio A
    Immune responses to EBNA1: biomarkers in MS?
    Neurology. 2009;73:13-4.
    PubMed     Text format     Related articles   
    
    
    June 2009
70. KHAN OA , Tselis A, Boster A
    Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Neurology. 2009;72:2134.
    PubMed     Text format     Related articles   
    
    
    
71. BEERAVOLU LR , Frohman EM, Frohman TC, Remington GM, et al
    Pearls & Oy-sters: "Not multiple sclerosis" and the changing face of HTLV-1: A case report of downbeat nystagmus.
    Neurology. 2009;72:e119-20.
    PubMed     Text format     Related articles   
    
    
    
72. YEH EA , Weinstock-Guttman B
    Moving on to second-line therapies in pediatric MS: Immunosuppression with cyclophosphamide.
    Neurology. 2009;72:2064-5.
    PubMed     Text format     Related articles   
    
    
    
73. RAMAGOPALAN SV , Yee IM, Dyment DA, Orton SM, et al
    Parent-of-origin effect in multiple sclerosis. Observations from interracial matings.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. D'NETTO MJ , Ward H, Morrison KM, Ramagopalan SV, et al
    Risk alleles for multiple sclerosis in multiplex families.
    Neurology. 2009;72:1984-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. FOLEY JF , Brandes DW
    Redefining functionality and treatment efficacy in multiple sclerosis.
    Neurology. 2009;72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. BRAILLON A , Dubois G
    Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
    Neurology. 2009;72:2053.
    PubMed     Text format     Related articles   
    
    
    
77. RUDICK RA , Pace A, Rani MR, Hyde R, et al
    Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
    Neurology. 2009;72:1989-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. FOX RJ , Arnold DL
    Seeing injectable MS therapies differently: they are more similar than different.
    Neurology. 2009;72:1972-3.
    PubMed     Text format     Related articles   
    
    
    
79. MARKOVIC-PLESE S , Jewells V, Speer D
    Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
    Neurology. 2009;72:1965.
    PubMed     Text format     Related articles   
    
    
    
80. NISHIYAMA S , Ito T, Misu T, Takahashi T, et al
    A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.
    Neurology. 2009;72:1960-1.
    PubMed     Text format     Related articles   
    
    
    
81. KIVISAKK P , Healy BC, Viglietta V, Quintana FJ, et al
    Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.
    Neurology. 2009;72:1922-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. GOLDSCHMIDT T , Antel J, Konig FB, Bruck W, et al
    Remyelination capacity of the MS brain decreases with disease chronicity.
    Neurology. 2009;72:1914-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
83. FARRELL RA , Antony D, Wall GR, Clark DA, et al
    Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. MOWRY EM , Beheshtian A, Waubant E, Goodin DS, et al
    Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.
    Neurology. 2009;72:1760-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. STEINER I
    Quantitative risk-benefit analysis of natalizumab.
    Neurology. 2009;72:1791-2.
    PubMed     Text format     Related articles   
    
    
    
86. MAKHANI N , Gorman MP, Branson HM, Stazzone L, et al
    Cyclophosphamide therapy in pediatric multiple sclerosis.
    Neurology. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. SELMAJ K , Jurewicz A, Matysiak M, Raine CS, et al
    Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis.
    Neurology. 2009;72:1708.
    PubMed     Text format     Related articles   
    
    
    
88. ROVARIS M , Barkhof F, Calabrese M, De Stefano N, et al
    MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
    Neurology. 2009;72:1693-701.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. GREEN AJ
    Understanding pseudo: the symptoms are real, the cause is unclear.
    Neurology. 2009;72:1626-7.
    PubMed     Text format     Related articles   
    
    
    
90. VILLOSLADA P , Arrondo G, Sepulcre J, Alegre M, et al
    Memantine induces reversible neurologic impairment in patients with MS.
    Neurology. 2009;72:1630-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. COHEN M , Rocher F, Brunschwig C, Lebrun C, et al
    Recurrent pericarditis due to natalizumab treatment.
    Neurology. 2009;72:1616-7.
    PubMed     Text format     Related articles   
    
    
    April 2009
92. CALABRESE M , Rocca MA, Atzori M, Mattisi I, et al
    Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.
    Neurology. 2009;72:1330-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. TEUNISSEN CE , Iacobaeus E, Khademi M, Brundin L, et al
    Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Neurology. 2009;72:1322-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. RODRIGUEZ M , Warrington AE, Pease LR
    Invited Article: Human natural autoantibodies in the treatment of neurologic disease.
    Neurology. 2009;72:1269-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
95. TENSER RB , Polman CH
    Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
    Neurology. 2009;72:1191-2.
    PubMed     Text format     Related articles   
    
    
    
96. BAHMANYAR S , Montgomery SM, Hillert J, Ekbom A, et al
    Cancer risk among patients with multiple sclerosis and their parents.
    Neurology. 2009;72:1170-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. HUSSAIN H , Usman A, Raza Q, Amato MP, et al
    Cognitive and psychosocial features of childhood and juvenile MS.
    Neurology. 2009;72:1189.
    PubMed     Text format     Related articles   
    
    
    
98. NAISMITH RT , Tutlam NT, Xu J, Klawiter EC, et al
    Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis.
    Neurology. 2009;72:1077-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. KLAWITER EC , Alvarez E 3rd, Xu J, Paciorkowski AR, et al
    NMO-IgG detected in CSF in seronegative neuromyelitis optica.
    Neurology. 2009;72:1101-3.
    PubMed     Text format     Related articles   
    
    
    
100. BADRUDDIN A , Menon RS, Reder AT
     4-Aminopyridine toxicity mimics autoimmune-mediated limbic encephalitis.
     Neurology. 2009;72:1100-1.
     PubMed     Text format     Related articles   
     
     
     
101. WIENDL H , Hohlfeld R
     Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.
     Neurology. 2009;72:1008-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. LEYPOLDT F , Munchau A, Moeller F, Bester M, et al
     Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
     Neurology. 2009;72:1022-4.
     PubMed     Text format     Related articles   
     
     
     
103. CHITNIS T , Pirko I
     Sensitivity vs specificity: progress and pitfalls in defining MRI criteria for pediatric MS.
     Neurology. 2009;72:952-3.
     PubMed     Text format     Related articles   
     
     
     
104. CADAVID D , Wolansky LJ, Skurnick J, Lincoln J, et al
     Efficacy of treatment of MS with IFN{beta}-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
     Neurology. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. BONHOMME GR , Waldman AT, Balcer LJ, Daniels AB, et al
     Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
     Neurology. 2009;72:881-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. MIKAELOFF Y , Caridade G, Suissa S, Tardieu M, et al
     Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
     Neurology. 2009;72:873-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. SAVOLAINEN H
     Cortical demyelination in PML and MS: similarities and differences.
     Neurology. 2009;72:861.
     PubMed     Text format     Related articles   
     
     
     
108. GOODMAN AD , Rossman H, Bar-Or A, Miller A, et al
     GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
     Neurology. 2009;72:806-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
109. MAGANA SM , Matiello M, Pittock SJ, McKeon A, et al
     Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
     Neurology. 2009;72:712-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. KOCH-HENRIKSEN N
     No shortcuts to outcome in MS clinical trials?
     Neurology. 2009;72:686-7.
     PubMed     Text format     Related articles   
     
     
     
111. KARCESKI S
     Neuromyelitis optica.
     Neurology. 2009;72:e40-1.
     PubMed     Text format     Related articles   
     
     
     
112. MOWRY EM , Pesic M, Grimes B, Deen S, et al
     Demyelinating events in early multiple sclerosis have inherent severity and recovery.
     Neurology. 2009;72:602-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. RUDICK RA , Fisher E
     Brain atrophy as an outcome measure for multiple sclerosis clinical trials: a "no-brainer"?
     Neurology. 2009;72:586-7.
     PubMed     Text format     Related articles   
     
     
     
114. RAMAGOPALAN SV , Ebers GC
     Epistasis: Multiple sclerosis and the major histocompatibility complex.
     Neurology. 2009;72:566-7.
     PubMed     Text format     Related articles   
     
     
     
115. COHEN JA , Imrey PB, Calabresi PA, Edwards KR, et al
     Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS.
     Neurology. 2009;72:535-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. SCHMIERER K , Parkes HG, So PW
     Direct visualization of remyelination in multiple sclerosis using T2-weighted high-field MRI.
     Neurology. 2009;72:472.
     PubMed     Text format     Related articles   
     
     
     
117. KHATRI BO , Man S, Giovannoni G, Koo AP, et al
     Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.
     Neurology. 2009;72:402-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. SCHIESS N , Calabresi PA
     Natalizumab: bound to rebound?
     Neurology. 2009;72:392-3.
     PubMed     Text format     Related articles   
     
     
     January 2009
119. PYLE W , Dastur K, Rahman M, Tsay J, et al
     Open-ring peripherally enhancing lesion of the cervical spine.
     Neurology. 2009;72:381.
     PubMed     Text format     Related articles   
     
     
     
120. WEISS N , Hasboun D, Demeret S, Fontaine B, et al
     Paroxysmal hypothermia as a clinical feature of multiple sclerosis.
     Neurology. 2009;72:193-5.
     PubMed     Text format     Related articles   
     
     
     
121. BECK CA
     Selection bias in observational studies: out of control?
     Neurology. 2009;72:108-9.
     PubMed     Text format     Related articles   
     
     
     
122. MARRIE RA , Horwitz R, Cutter G, Tyry T, et al
     Comorbidity delays diagnosis and increases disability at diagnosis in MS.
     Neurology. 2009;72:117-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. MESSINIS L , Papathanasopoulos P
     Multiple sclerosis and cannabis: a cognitive and psychiatric study.
     Neurology. 2009;72:100-1.
     PubMed     Text format     Related articles   
     
     
     
124. O'CONNOR P , Comi G, Montalban X, Antel J, et al
     Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study.
     Neurology. 2009;72:73-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
125. NESS JM , Bale JF Jr
     Hepatitis vaccines and pediatric multiple sclerosis. Does timing or type matter?
     Neurology. 2008.
     PubMed     Text format     Related articles   
     
     
     
126. OKUDA DT , Mowry EM, Beheshtian A, Waubant E, et al
     Incidental MRI anomalies suggestive of multiple sclerosis. The radiologically isolated syndrome.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. DAUMER M , Neuhaus A, Morrissey S, Hintzen R, et al
     MRI as an outcome in multiple sclerosis clinical trials.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. BOURDETTE D , Simon J
     The radiologically isolated syndrome. Is it very early multiple sclerosis?
     Neurology. 2008.
     PubMed     Text format     Related articles   
     
     
     
129. YSRRAELIT MC , Gaitan MI, Lopez AS, Correale J, et al
     Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis.
     Neurology. 2008;71:1948-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. GOODIN DS
     Disease-modifying therapy in multiple sclerosis: Update and clinical implications.
     Neurology. 2008;71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. COYLE PK
     Early treatment of multiple sclerosis to prevent neurologic damage.
     Neurology. 2008;71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. COHEN BA
     Identification, causation, alleviation, and prevention of complications (ICAP): An approach to symptom and disability management in multiple sclerosis.
     Neurology. 2008;71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. ROSS AP
     Strategies for optimal disease management, adherence, and outcomes in multiple sclerosis patients.
     Neurology. 2008;71.
     PubMed     Text format     Related articles   
     
     
     
134. ROSS AP
     Tolerability, adherence, and patient outcomes.
     Neurology. 2008;71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. DOHERTY MJ
     Reflections: Neurology and the humanities. Ferris wheels, fly fishing, and the dumping.
     Neurology. 2008;71:2015-7.
     PubMed     Text format     Related articles   
     
     
     
136. SORENSEN PS
     Can we spot the IFNbeta nonresponders?
     Neurology. 2008;71:1936-7.
     PubMed     Text format     Related articles   
     
     
     November 2008
137. CALLEN DJ , Shroff MM, Branson HM, Lotze T, et al
     MRI in the diagnosis of pediatric multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. CALLEN DJ , Shroff MM, Branson HM, Li DK, et al
     Role of MRI in the differentiation of ADEM from MS in children.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. BURTON JM , Bell CM, Walker SE, O'Connor PW, et al
     4-aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis.
     Neurology. 2008;71:1833-4.
     PubMed     Text format     Related articles   
     
     
     
140. KUMPFEL T , Hoffmann LA, Pellkofer H, Pollmann W, et al
     Multiple sclerosis and the TNFRSF1A R92Q mutation: Clinical characteristics of 21 cases.
     Neurology. 2008;71:1812-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. STUVE O , Cravens PD, Frohman EM, Phillips JT, et al
     Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. VILLOSLADA P , Sepulcre J, Toledo J, Bejarano B, et al
     Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
     Neurology. 2008;71:1747-8.
     PubMed     Text format     Related articles   
     
     
     
143. ALTMANN DR , Jasperse B, Barkhof F, Beckmann K, et al
     Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
144. GILLI F , Valentino P, Caldano M, Granieri L, et al
     Expression and regulation of IFN{alpha}/{beta} receptor in IFN{beta}-treated patients with multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. 
     About multiple sclerosis.
     Neurology. 2008;71:e56.
     PubMed     Text format     Related articles   
     
     
     
146. GOLDMAN MD , Cohen JA
     Statins to treat multiple sclerosis: friend or foe?
     Neurology. 2008;71:1386-7.
     PubMed     Text format     Related articles   
     
     
     
147. LOCK C
     Are "statins" beneficial or harmful in multiple sclerosis?
     Neurology. 2008;71:e54-5.
     PubMed     Text format     Related articles   
     
     
     
148. RAMAGOPALAN SV , Dyment DA, Sadovnick AD, Ebers GC, et al
     Re: HLA-DRB1 and multiple sclerosis in Malta.
     Neurology. 2008;71:1379.
     PubMed     Text format     Related articles   
     
     
     
149. KRUMBHOLZ M , Meinl I, Kumpfel T, Hohlfeld R, et al
     Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.
     Neurology. 2008;71:1350-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. BURTON JM , Bell CM, Walker SE, O'Connor PW, et al
     4-Aminopyridine toxicity with unintentional overdose in four patients with multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles   
     
     
     
151. MEHLING M , Brinkmann V, Antel J, Bar-Or A, et al
     FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
     Neurology. 2008;71:1261-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. MAZUREK AA , Shi J
     APOE epsilon4 allele is associated with cognitive impairment in patients with multiple sclerosis.
     Neurology. 2008;71:1203.
     PubMed     Text format     Related articles   
     
     
     
153. BAR-OR A , Antel J
     Cross-reactivity between epidemiology and immunology in multiple sclerosis.
     Neurology. 2008;71:1132-3.
     PubMed     Text format     Related articles   
     
     
     
154. KRYSCIO RJ
     Fampridine for MS responders: clinically relevant or hypothesis generating?
     Neurology. 2008;71:1130-1.
     PubMed     Text format     Related articles   
     
     
     September 2008
155. CHABAS D , Castillo-Trivino T, Mowry EM, Strober JB, et al
     Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?
     Neurology. 2008;71:1090-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. ROVARIS M , Riccitelli G, Judica E, Possa F, et al
     Cognitive impairment and structural brain damage in benign multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. LUNEMANN JD , Huppke P, Roberts S, Bruck W, et al
     Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis.
     Neurology. 2008;71:1033-5.
     PubMed     Text format     Related articles   
     
     
     
158. BANWELL BL
     Into the looking glass: predicting MS in children experiencing a first demyelinating event.
     Neurology. 2008;71:962-3.
     PubMed     Text format     Related articles   
     
     
     
159. NEUTEBOOM RF , Boon M, Catsman Berrevoets CE, Vles JS, et al
     Prognostic factors after a first attack of inflammatory CNS demyelination in children.
     Neurology. 2008;71:967-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. VIGLIETTA V , Bourcier K, Buckle GJ, Healy B, et al
     CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial.
     Neurology. 2008;71:917-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. KANTARCI OH , Spurkland A
     Parent of origin in multiple sclerosis: understanding inheritance in complex neurologic diseases.
     Neurology. 2008;71:786-7.
     PubMed     Text format     Related articles   
     
     
     
162. HERRERA BM , Ramagopalan SV, Lincoln MR, Orton SM, et al
     Parent-of-origin effects in MS: observations from avuncular pairs.
     Neurology. 2008;71:799-803.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. GOODIN DS , Cohen BA, O'Connor P, Kappos L, et al
     Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
     Neurology. 2008;71:766-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
164. WANG H , Munger KL, Reindl M, O'Reilly EJ, et al
     Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. AMATO MP , Portaccio E, Stromillo ML, Goretti B, et al
     Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
     Neurology. 2008;71:632-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. MARRIE RA
     You get what you measure: evaluating endpoints in MS clinical trials.
     Neurology. 2008;71:620-1.
     PubMed     Text format     Related articles   
     
     
     
167. EBERS GC , Heigenhauser L, Daumer M, Lederer C, et al
     Disability as an outcome in MS clinical trials.
     Neurology. 2008;71:624-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. DWYER T , van der Mei I, Ponsonby AL, Taylor BV, et al
     Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis.
     Neurology. 2008;71:583-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. BRENNER SR , Brown MG, Kirby S, Skedgel C, et al
     How effective are disease-modifying drugs in delaying progression in relapsing-onset ms?
     Neurology. 2008;71:615.
     PubMed     Text format     Related articles   
     
     
     
170. ZWERGAL A , Cnyrim C, Arbusow V, Glaser M, et al
     Unilateral INO is associated with ocular tilt reaction in pontomesencephalic lesions: INO plus.
     Neurology. 2008;71:590-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. WILKINS DE
     Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?
     Neurology. 2008;71:463.
     PubMed     Text format     Related articles   
     
     
     
172. MILLS DA , Frohman TC, Davis SL, Salter AR, et al
     Break in binocular fusion during head turning in ms patients with ino.
     Neurology. 2008;71:458-60.
     PubMed     Text format     Related articles   
     
     
     
173. BOSCA I , Pascual AM, Casanova B, Coret F, et al
     Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone.
     Neurology. 2008;71:457-8.
     PubMed     Text format     Related articles   
     
     
     July 2008
174. GOODMAN AD , Brown TR, Cohen JA, Krupp LB, et al
     Dose comparison trial of sustained-release fampridine in multiple sclerosis.
     Neurology. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. THOMPSON JP , Noyes K, Dorsey ER, Schwid SR, et al
     Quantitative risk-benefit analysis of natalizumab.
     Neurology. 2008;71:357-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. FAZEKAS F , Lublin FD, Li D, Freedman MS, et al
     Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
     Neurology. 2008;71:265-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. ARNETT PA
     Cannabis bliss? Perhaps not?
     Neurology. 2008;71:160-1.
     PubMed     Text format     Related articles   
     
     
     
178. ZIVADINOV R , Reder AT, Filippi M, Minagar A, et al
     Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.
     Neurology. 2008;71:136-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. ALONSO A , Hernan MA
     Temporal trends in the incidence of multiple sclerosis: a systematic review.
     Neurology. 2008;71:129-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. GOUT O
     Re: Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
     Neurology. 2008;71:69.
     PubMed     Text format     Related articles   
     
     
     June 2008
181. BIRNBAUM G , Cree B, Altafullah I, Zinser M, et al
     Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
     Neurology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. GIOVANNONI G
     To test or not to test: NMO-IgG and optic neuritis.
     Neurology. 2008;70:2192-3.
     PubMed     Text format     Related articles   
     
     
     
183. MATIELLO M , Lennon VA, Jacob A, Pittock SJ, et al
     NMO-IgG predicts the outcome of recurrent optic neuritis.
     Neurology. 2008;70:2197-200.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
184. MCKEON A , Lennon VA, Lotze T, Tenenbaum S, et al
     CNS aquaporin-4 autoimmunity in children.
     Neurology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. TALLANTYRE EC , Brookes MJ, Dixon JE, Morgan PS, et al
     Demonstrating the perivascular distribution of ms lesions in vivo with 7-tesla MRI.
     Neurology. 2008;70:2076-8.
     PubMed     Text format     Related articles   
     
     
     
186. DE SEZE J , Arndt C, Jeanjean L, Zephir H, et al
     Relapsing inflammatory optic neuritis: is it neuromyelitis optica?
     Neurology. 2008;70:2075-6.
     PubMed     Text format     Related articles   
     
     
     
187. LINDSEY JW , Crawford MP, Hatfield LM
     Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis.
     Neurology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. AMATO MP , Goretti B, Ghezzi A, Lori S, et al
     Cognitive and psychosocial features of childhood and juvenile MS.
     Neurology. 2008;70:1891-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2008
189. FOLDEN DV , Lee MS, Ryan EH Jr
     INTERFERON {beta}-ASSOCIATED RETINOPATHY IN PATIENTS TREATED FOR MULTIPLE SCLEROSIS.
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
190. MINDEN SL , Hoaglin DC, Hadden L, Frankel D, et al
     Access to and utilization of neurologists by people with multiple sclerosis.
     Neurology. 2008;70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. POLMAN CH , Reingold SC, Barkhof F, Calabresi PA, et al
     Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessment.
     Neurology. 2008;70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. BANWELL BL , Sled JG
     Starting early: MRI evidence of gray matter atrophy in children with multiple sclerosis.
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
193. SRIRAM S
     TRAPS and MS: two diseases or an MS mimic?
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
194. FOX RJ , Kappos L
     Is natalizumab overshooting its rebound?
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
195. RATCHFORD JN , Calabresi PA
     The diagnosis of MS: white spots and red flags.
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
196. RUDICK RA , Ransohoff RM
     Biomarkers for interferon response in MS: are we there yet?
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
197. MARRIE RA
     When one and one make three: HLA and EBV infection in MS.
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
198. CUTTER GR , Lublin FD
     Responsiveness and predictive values in PPMS: an uncertain message.
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
199. HINTZEN RQ , Giovannoni G
     CSF analysis in suspected MS: do bands aid?
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
200. KEEGAN BM , Giannini C, Parisi JE, Lucchinetti CF, et al
     Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS.
     Neurology. 2008;70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. LEIGH RJ , Serra A
     Taking the temperature of MS with INO.
     Neurology. 2008;70.
     PubMed     Text format     Related articles   
     
     
     
202. KRAGT JJ , Thompson AJ, Montalban X, Tintore M, et al
     Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
     Neurology. 2008;70.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
203. VERNY C , Loiseau D, Scherer C, Lejeune P, et al
     Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy.
     Neurology. 2008;.
     PubMed     Text format     Related articles   
     
     
     
204. HOFFMANN LA , Lohse P, Konig FB, Feneberg W, et al
     TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome.
     Neurology. 2008;.
     PubMed     Text format     Related articles   
     
     
     
205. DAVIS SL , Frohman TC, Crandall CG, Brown MJ, et al
     Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.
     Neurology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. MESAROS S , Rocca MA, Absinta M, Ghezzi A, et al
     Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
     Neurology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. DE JAGER PL , Simon KC, Munger KL, Rioux JD, et al
     Integrating risk factors. HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
     Neurology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. MALUCCHI S , Gilli F, Caldano M, Marnetto F, et al
     Predictive markers for response to interferon therapy in patients with multiple sclerosis.
     Neurology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. GHAFFAR O , Feinstein A
     Multiple sclerosis and cannabis. A cognitive and psychiatric study.
     Neurology. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2008
210. LEVY M , Birnbaum J, Kerr D
     Finding NMO: neuromyelitis optica in children.
     Neurology. 2008;70:334-5.
     PubMed     Text format     Related articles   
     
     
     
211. LASSMANN H , Lucchinetti CF
     Cortical demyelination in CNS inflammatory demyelinating diseases.
     Neurology. 2008;70:332-3.
     PubMed     Text format     Related articles   
     
     
     
212. ESPINOSA PS
     Teaching NeuroImage: one-and-a-half syndrome.
     Neurology. 2008;70:e20.
     PubMed     Text format     Related articles   
     
     
     
213. BANWELL B , Tenembaum S, Lennon VA, Ursell E, et al
     Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
     Neurology. 2008;70:344-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. PHILLIPS MD
     Functional faults: fMRI in MS.
     Neurology. 2008;70:248-9.
     PubMed     Text format     Related articles   
     
     
     
215. ROCCA MA , Tortorella P, Ceccarelli A, Falini A, et al
     The "mirror-neuron system" in MS: A 3 tesla fMRI study.
     Neurology. 2008;70:255-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. SADOVNICK AD , Jacobs DH
     MS and cognition and APOE: the ongoing conundrum about biomarkers.
     Neurology. 2008;70:164-5.
     PubMed     Text format     Related articles   
     
     
     
217. FEYS P , Helsen W, Nuttin B, Lavrysen A, et al
     Unsteady gaze fixation enhances the severity of MS intention tremor.
     Neurology. 2008;70:106-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. FONTAINE B , Barcellos LF
     Evidence for a complex interaction between HLA-DRB1 and environmental factors in MS.
     Neurology. 2008;70:97-8.
     PubMed     Text format     Related articles   
     
     
     December 2007
219. HINSON SR , Pittock SJ, Lucchinetti CF, Roemer SF, et al
     Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
     Neurology. 2007;69:2221-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2007
220. MOLL NM , Rietsch AM, Ransohoff AJ, Cossoy MB, et al
     Cortical demyelination in PML and MS: Similarities and differences.
     Neurology. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2007
221. VELLINGA MM , Castelijns JA, Barkhof F, Uitdehaag BM, et al
     Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients.
     Neurology. 2007;.
     PubMed     Text format     Related articles   
     
     

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: